Serve You Rx, a pharmacy benefit manager, has added two recently approved biosimilars to Stelara to its formulary, the company announced Thursday.

Milwaukee, Wisconsin-based Serve You Rx is an independent PBM serving insurance brokers, consultants, third-party administrators and their employer clients.

The two biosimilars it added to its formulary are Otulfi and Yesintek, which are used to treat patients for Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis. A biosimilar is a medicine that is very similar in structure and function to a brand name biologic medicine, but is significantly cheaper. Stelara is about $20,000 per month, according to Serve You Rx CEO Justin Jasniewski, but the company will be able to help clients save about 96% with Otulfi and abo

See Full Page